Pralatrexate Induces Long-Term Remission in Relapsed Subcutaneous Panniculitis-Like T-Cell Lymphoma

Ann Acad Med Singap. 2019 Sep;48(9):298-300.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Aminopterin / analogs & derivatives*
  • Aminopterin / therapeutic use
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bone Marrow / pathology
  • Cisplatin / administration & dosage
  • Cyclophosphamide
  • Deoxycytidine / administration & dosage
  • Deoxycytidine / analogs & derivatives
  • Dexamethasone / administration & dosage
  • Doxorubicin
  • Folic Acid Antagonists / therapeutic use*
  • Gemcitabine
  • Humans
  • Lymphohistiocytosis, Hemophagocytic / etiology
  • Lymphohistiocytosis, Hemophagocytic / pathology
  • Lymphoma, T-Cell, Peripheral / complications
  • Lymphoma, T-Cell, Peripheral / drug therapy*
  • Lymphoma, T-Cell, Peripheral / pathology
  • Male
  • Neoplasm Recurrence, Local / drug therapy*
  • Panniculitis
  • Prednisone
  • Remission Induction
  • Subcutaneous Fat, Abdominal / pathology
  • Vincristine

Substances

  • 10-propargyl-10-deazaaminopterin
  • Folic Acid Antagonists
  • Deoxycytidine
  • Vincristine
  • Dexamethasone
  • Doxorubicin
  • Cyclophosphamide
  • Aminopterin
  • Cisplatin
  • Prednisone
  • Gemcitabine

Supplementary concepts

  • CHOP protocol